Basilea Pharmaceutica (Basilea Pharmaceutica) Other Current Liabilities : $28.0 Mil (As of Dec. 2023)

View and export this data going back to 2004. Start your Free Trial

What is Basilea Pharmaceutica Other Current Liabilities?

Basilea Pharmaceutica's other current liabilities for the quarter that ended in Dec. 2023 was $28.0 Mil.

Basilea Pharmaceutica's quarterly other current liabilities declined from Dec. 2022 ($37.8 Mil) to Jun. 2023 ($25.3 Mil) but then increased from Jun. 2023 ($25.3 Mil) to Dec. 2023 ($28.0 Mil).

Basilea Pharmaceutica's annual other current liabilities declined from Dec. 2021 ($41.1 Mil) to Dec. 2022 ($37.8 Mil) and declined from Dec. 2022 ($37.8 Mil) to Dec. 2023 ($28.0 Mil).

Basilea Pharmaceutica Other Current Liabilities Historical Data

The historical data trend for Basilea Pharmaceutica's Other Current Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Basilea Pharmaceutica Other Current Liabilities Chart

Basilea Pharmaceutica Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Other Current Liabilities

Get a 7-Day Free Trial

Basilea Pharmaceutica Semi-Annual Data
	Jun14	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Other Current Liabilities	Get a 7-Day Free Trial															-	-	-	-	-

Basilea Pharmaceutica Other Current Liabilities Calculation

The liability a company needs to pay in the next 12 months, but not assigned to Accounts Payable or Debt. For instance, Wal-Mart (WMT) has accrued wages, salaries, valuation, bonuses, insurance liabilities, accrued tax etc. These are all included in other current liabilities.

Basilea Pharmaceutica Other Current Liabilities Related Terms

Thank you for viewing the detailed overview of Basilea Pharmaceutica's Other Current Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.

Basilea Pharmaceutica (Basilea Pharmaceutica) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Basilea Pharmaceutica Ltd (OTCPK:BPMUF) » Definitions » Other Current Liabilities

Comparable Companies

Traded in Other Exchanges

BSLNz:UK BSLN:Switzerland

Address

Switzerland Innovation Park, Basel Area, Main Campus, Near Basel, Allschwil, CHE, 4058

Website

https://www.basilea.com

Basilea Pharmaceutica Ltd is a commercial-stage biopharmaceutical company committed to discovering, developing and commercializing drugs to meet the needs of patients with severe bacterial and fungal infections. The Company has operating subsidiaries in the United Kingdom and Germany. Geographically company derives revenue from Japan, Ireland, Republic of Korea, USA, Uruguay, Sweden, Canada, Jordan, Switzerland and Other countries.

Basilea Pharmaceutica (Basilea Pharmaceutica) Headlines

From GuruFocus

Forge And Basilea Enter Into Multi-Target Agreement To Discover And Develop Novel Antibiotics

By PRNewswire PRNewswire • 04-24-2019